Last month, BEL software SOURCERER achieved FDA 510(k) clearance.
“FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom.
BEL Company was founded in 2017 after a successful sale of a previous company in order to expand the research and development of neuroscience technology. BEL has continued to develop groundbreaking software and hardware innovations for EEG and the study of the human brain.
In 2022, Neurosom was founded in order to bring Sleep Therapy technology to commercial market. Neurosom shares both an expert, experienced medical device management team and a Quality Management System with partner company BEL. “BEL’s high density electroencephalography (hdEEG) system provides an important technology for Neurosom’s advanced sleep research. The achievement of this FDA 510(k) clearance for the partner company of Neurosom gives our management team valuable experience with the regulatory approval process,” says Tucker. “Every milestone strengthens our team and our pathway forward.”
Learn more about Nuerosom and its capital raise here.
Securities are offered through Alira Health Transactions Services, member FINRA/SIPC.
